Pharma BD Deal Intelligence
Roche acquired Verum Diagnostica for €11M cash plus up to €2M in milestones, calling platelet function testing 'a significant unmet need' and the…
Roche acquires 100% of Verum Diagnostica as part of a plan to develop a comprehensive coagulation testing portfolio, adding the Multiplate platelet function…
Roche acquires Verum Diagnostica, characterized as the leader in platelet function testing, the fastest-growing field in the coagulation diagnostics market.
Source summaries from our enrichment pipeline; follow links for originals.
All 6 sources with sentiment breakdown →
Roche acquired Verum Diagnostica for €11M cash plus up to €2M in milestones (~$17M total), expanding its coagulation diagnostics portfolio. Below $250M threshold but a clean diagnostics-platform tuck-in.
Assessment window: 5yr post-close.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Roche Holding AG / Verum Diagnostica GmbH (this deal) | 2011 | $17M | 56 |
| Roche Holding AG / Chugai Pharmaceutical Co. Ltd. | 2002 | $1.4B | 100 |
| Roche Holding AG / Ventana Medical Systems Inc. | 2008 | $3.4B | 88 |
| Roche Holding AG / Corange Ltd. (Boehringer Mannheim Group) | 1997 | $11.0B | 88 |
| Roche Holding AG / Ventana Medical Systems Inc. | 2007 | $3.4B | 88 |
| Roche Holding AG / Foundation Medicine, Inc. | 2015 | $1.1B | 87 |
| Roche Holding AG / Foundation Medicine, Inc. | 2018 | $5.3B | 85 |
← Browse all deals · How we score deals
More: 2011 deals · Roche Holding AG deals · Other deals